Delivery Order SPE2DB20D3103-SPE2DB25FQ0X9
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for OmniPod 5 Dexcom G7 generation 5 insulin infusion pump pods. This $32,078.67 firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, represents a competitive award with no set-aside designation. The products will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $84,729.11 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pump pods on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $9,090.51 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Gen 5 insulin infusion pump pods on August 21, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the vendor's demonstrated capability to compete...
- The Defense Logistics Agency awarded a $1,804.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pump pods. This non-set-aside competitive award was issued on July 29, 2025, with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,715.24 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 insulin infusion pump pods (Generation 5) with a completion date of August 28, 2025. This non-competed delivery order utilizes firm fixed pricing and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is positioned as a critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Gen 5 insulin infusion pods valued at $1,222.32. This competitive, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical...
- The Defense Logistics Agency awarded a $2,395.34 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device delivery, which supports the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $5,055.69 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin pump pods on August 28, 2025, with completion scheduled for August 29, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a small transaction within AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a $2,934.92 delivery order to AmerisourceBergen Drug Corp for Omnipod 5 Dexcom G7 Generation 5 insulin infusion pump pods. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $11,903.46 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Gen 5 insulin infusion pump pods. This firm fixed price, non-set-aside contract was executed on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a critical medical supply for military and veteran healthcare systems...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ0X9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Omnipod 5 Dexcom G7 Generation 5 insulin infusion pump pods. The order, valued at $5,449.29, is structured as a firm fixed price delivery order with an ultimate completion date of September 2, 2025. AmerisourceBergen will fulfill this requirement from its corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without any set-aside designation, reflecting the vendor's demonstrated capability to meet federal procurement standards through open competition. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical supply agreement running through December 2026. The parent IDC enables AmerisourceBergen to supply a broad spectrum of pharmaceutical products and medical devices to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. As a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, AmerisourceBergen maintains a significant role in the DLA's pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 8/29/25 |